Centessa Pharmaceuticals (CNTA) Debt to Equity (2022 - 2025)
Historic Debt to Equity for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $0.36.
- Centessa Pharmaceuticals' Debt to Equity rose 14010.19% to $0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.36, marking a year-over-year increase of 14010.19%. This contributed to the annual value of $0.27 for FY2024, which is 1533.22% down from last year.
- Latest data reveals that Centessa Pharmaceuticals reported Debt to Equity of $0.36 as of Q3 2025, which was up 14010.19% from $0.32 recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Debt to Equity ranged from a high of $0.36 in Q3 2025 and a low of $0.15 during Q3 2024
- Over the past 4 years, Centessa Pharmaceuticals' median Debt to Equity value was $0.27 (recorded in 2024), while the average stood at $0.26.
- Per our database at Business Quant, Centessa Pharmaceuticals' Debt to Equity plummeted by 4683.85% in 2024 and then surged by 14010.19% in 2025.
- Over the past 4 years, Centessa Pharmaceuticals' Debt to Equity (Quarter) stood at $0.21 in 2022, then skyrocketed by 54.33% to $0.32 in 2023, then dropped by 15.33% to $0.27 in 2024, then skyrocketed by 34.22% to $0.36 in 2025.
- Its Debt to Equity stands at $0.36 for Q3 2025, versus $0.32 for Q2 2025 and $0.28 for Q1 2025.